MedicarePartD.guide

A non-government resource built from CMS public data

NUCALA 100 mg/mL Injection, Solution

Also known as Mepolizumab. Coverage in Hawaii (CMS PDP Region 33).

1 of 8 stand-alone Part D plans in Hawaii cover this drug on tier 5.

1 of 1 plans apply a prior authorization, step therapy or quantity limit.

18 Medicare Advantage plans in HI do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. HI: 18 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Preferred from UHC (PDP)$139.20/mo premium · $130.00 deductible5Specialty Tier31%—$4004.7125$12,014.143 units
  • Prior authorization
  • Quantity limit 3 per 28 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →